KLRK1 and neoplasm: Notably, dacarbazine was shown to upregulate the expression of NKG2D ligands on tumor cells, thus promoting NK-cell cytotoxicity and IFN-γ secretion (52), which might have further enhanced the role exerted by NK cells in arm 2 patients.